Articles

Corporate Membership

Details

Category: Author Resources

Published on Thursday, 19 May 2005 13:30

Hits: 2115

If your company provides products and services to the gene therapy community or if your institution is developing gene-based medicines we recommend that you become a corporate member of the Gene Therapy Review.

Corporate membership is specifically aimed at companies wishing to promote their services throughout our website to the broader gene therapy community and allows for increased exposure of your services. This is a new service designed to incorporate all the benefits of advertising on the Gene Therapy Review into a single, easy-to-manage package.

Benefits include:

1. Establishment and maintenance of a page devoted to your company, its products and services in the relevant section of our website (linked to from our homepage for a fixed period of time; at least 3 months)

2. Unlimited advertising on the site in sections chosen by you, e.g. banner or box ads

3. Unlimited posting of job vacancies in your company

4. Full page advert in the yearly print issue distributed by EBSCO and available for purchase through Amazon

5. Unlimited press releases published on the site, again linked to from the homepage for a fixed period of time (at least 3 months)

6. Unlimited articles describing the application of your technology

7. Yearly support to enable updates to your company page

8. Advanced ad tracking system to monitor who is clicking your ads and viewing your page

9. Exposure of your pages throughout our network of iphone and android app users

For a limited time period we are now charging an introductory price of $299 for annual subscription to this service; with revenue obtained from this nominal corporate membership fee helping keep the Gene Therapy Review an open resource for the broader scientific community.

We are able to convert your existing marketing material into a company page at your request.

If you are interested in listing your company on the Gene Therapy Review please contact the Editor-in-Chief, Dr Michael Roberts at using this contact form.

Join today to benefit from all these services and increase your company's profile and activities in the growing arena of gene therapy

• < Prev